California Public Employees Retirement System Sells 8,575 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

California Public Employees Retirement System decreased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 2.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 359,807 shares of the company’s stock after selling 8,575 shares during the quarter. California Public Employees Retirement System owned about 0.39% of Acadia Healthcare worth $27,979,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Headlands Technologies LLC bought a new position in Acadia Healthcare in the third quarter valued at approximately $25,000. Fifth Third Bancorp lifted its stake in Acadia Healthcare by 25.5% in the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after buying an additional 136 shares in the last quarter. DekaBank Deutsche Girozentrale bought a new position in Acadia Healthcare in the third quarter valued at approximately $96,000. Oak Thistle LLC bought a new position in Acadia Healthcare in the fourth quarter valued at approximately $235,000. Finally, Advisor Partners II LLC raised its holdings in shares of Acadia Healthcare by 7.5% in the third quarter. Advisor Partners II LLC now owns 3,351 shares of the company’s stock valued at $236,000 after purchasing an additional 234 shares during the last quarter.

Analyst Ratings Changes

A number of brokerages recently weighed in on ACHC. UBS Group boosted their target price on shares of Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a report on Wednesday, February 28th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a research report on Monday, March 4th. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 target price for the company in a research report on Thursday. Barclays began coverage on shares of Acadia Healthcare in a research report on Wednesday, March 6th. They issued an “overweight” rating and a $100.00 target price for the company. Finally, TheStreet raised shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research report on Monday, March 4th. Four equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, Acadia Healthcare currently has an average rating of “Moderate Buy” and an average price target of $92.00.

Insider Activity

In related news, Director Wade D. Miquelon sold 2,203 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the completion of the transaction, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 2.80% of the stock is currently owned by corporate insiders.

Acadia Healthcare Trading Up 0.3 %

ACHC opened at $73.59 on Friday. The company’s 50 day moving average is $78.07 and its 200-day moving average is $77.70. Acadia Healthcare Company, Inc. has a 1-year low of $66.49 and a 1-year high of $87.77. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. The company has a market cap of $6.80 billion, a P/E ratio of -294.35, a PEG ratio of 2.17 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.80 by $0.05. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The company had revenue of $742.80 million for the quarter, compared to the consensus estimate of $727.60 million. During the same period last year, the company posted $0.70 EPS. The firm’s quarterly revenue was up 10.0% compared to the same quarter last year. Equities research analysts predict that Acadia Healthcare Company, Inc. will post 3.57 earnings per share for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.